Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))

Research output: Contribution to journalComment/debatepeer-review

4 Downloads (Pure)

Abstract

The authors regret that the printed version of the above article missed to include the funding details. The correct and final version follows. The authors would like to apologise for any inconvenience caused. The present publication was funded by Fundação para a Ciência e a Tecnologia, IP national support through CHRC (UIDB/04923/2020). The study was supported by unrestricted grants from Direcção-Geral da Saúde, aFundação Calouste Gulbenkian, Fundação Champalimaud, Fundação AstraZeneca, Abbvie, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Center de Medicina Laboratorial Germano de Sousa, Clínica Médica da Praia da Vitória, CAL-Clínica, Galp Energia, Açoreana Seguros, and individual rheumatologists.

Original languageEnglish
Article number101691
JournalBone Reports
DOIs
Publication statusE-pub ahead of print - 2023

Fingerprint

Dive into the research topics of 'Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))'. Together they form a unique fingerprint.

Cite this